Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Effects of β-Blockers on the Sympathetic and Cytokines Storms in Covid-19
Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, Gomaa Mostafa‐Hedeab, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 54

Showing 1-25 of 54 citing articles:

Neutrophil Extracellular Traps (NETs) and Covid-19: A new frontiers for therapeutic modality
Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, Hany Akeel Al-Hussaniy, et al.
International Immunopharmacology (2022) Vol. 104, pp. 108516-108516
Open Access | Times Cited: 144
Role of Neuropilin 1 in COVID-19 Patients with Acute Ischemic Stroke
Asma W. Al-Thomali, Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, et al.
Biomedicines (2022) Vol. 10, Iss. 8, pp. 2032-2032
Open Access | Times Cited: 38
Atomized Neutrophil Membrane-coated MOF Nanoparticles for Direct Delivery of Dexamethasone for Severe Pneumonia
Yixiao Yang, Lizhen Yan, Han Zhang, et al.
Frontiers in Bioscience-Landmark (2025) Vol. 30, Iss. 1
Open Access
Interleukin-6 related signaling pathways as the intersection between chronic diseases and sepsis
Jie Yang, Lin Yang, Yanjiao Wang, et al.
Molecular Medicine (2025) Vol. 31, Iss. 1
Open Access
Cholinergic dysfunction in COVID-19: frantic search and hoping for the best
Eman Hassan Nadwa, Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2022) Vol. 396, Iss. 3, pp. 453-468
Open Access | Times Cited: 28
Sympathetic System in Wound Healing: Multistage Control in Normal and Diabetic Skin
E. V. Ivanov, Marina Akhmetshina, Aleksei Erdiakov, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 3, pp. 2045-2045
Open Access | Times Cited: 15
Interplay of TLR4 and SARS-CoV-2: Unveiling the Complex Mechanisms of Inflammation and Severity in COVID-19 Infections
Njinju Asaba Clinton, Cyril Jabea Ekabe, Humblenoble Stembridge Ayuk, et al.
Journal of Inflammation Research (2024) Vol. Volume 17, pp. 5077-5091
Open Access | Times Cited: 5
Selinexor and COVID-19: The Neglected Warden
Gomaa Mostafa‐Hedeab, Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 24
Beta-blockers in cardiac arrhythmias–Clinical pharmacologist’s point of view
Łukasz Wołowiec, Grzegorz Grześk, Joanna Osiak, et al.
Frontiers in Pharmacology (2023) Vol. 13
Open Access | Times Cited: 13
Long COVID and risk of erectile dysfunction in recovered patients from mild to moderate COVID-19
Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, Sumaiah J. Alarfaj, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 12
The Important Role of Interleukin-2 in COVID-19
Leila Ghanbari Naeini, Laleh Abbasi, Farzaneh Karimi, et al.
Journal of Immunology Research (2023) Vol. 2023, pp. 1-13
Open Access | Times Cited: 11
Catecholamines Are the Key Trigger of COVID-19 mRNA Vaccine-Induced Myocarditis: A Compelling Hypothesis Supported by Epidemiological, Anatomopathological, Molecular, and Physiological Findings
Flavio Cadegiani
Cureus (2022)
Open Access | Times Cited: 18
Mixed storm in SARS‐CoV‐2 infection: A narrative review and new term in the Covid‐19 era
Basil Mohammed Alomair, Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, et al.
Immunity Inflammation and Disease (2023) Vol. 11, Iss. 4
Open Access | Times Cited: 11
Antidepressants and type 2 diabetes: highways to knowns and unknowns
Nahi Sabih Alruwaili, Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, et al.
Diabetology & Metabolic Syndrome (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 10
SARS-CoV-2 infection and dysregulation of nuclear factor erythroid-2-related factor 2 (Nrf2) pathway
Rabab S. Hamad, Hayder M. Al‐kuraishy, Αθανάσιος Αλεξίου, et al.
Cell Stress and Chaperones (2023) Vol. 28, Iss. 6, pp. 657-673
Open Access | Times Cited: 10
An overview of the efficacy and safety of β 2 -adrenoceptor antagonists for the treatment of chronic obstructive pulmonary disease
Maria Gabriella Matera, Paola Rogliani, Luigino Calzetta, et al.
Expert Opinion on Drug Safety (2024) Vol. 23, Iss. 7, pp. 833-844
Closed Access | Times Cited: 3
Neuromodulation Strategies to Reduce Inflammation and Improve Lung Complications in COVID-19 Patients
Christopher J. Czura, Marom Bikson, Leigh Charvet, et al.
Frontiers in Neurology (2022) Vol. 13
Open Access | Times Cited: 17
Citicoline and COVID-19: vis-à-vis conjectured
Hayder M. Al‐kuraishy, Ali K. Albuhadily, Ali I. Al‐Gareeb, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2022) Vol. 395, Iss. 12, pp. 1463-1475
Open Access | Times Cited: 15
Neurological complications caused by SARS-CoV-2
Zehan Pang, Ao Tang, Yujie He, et al.
Clinical Microbiology Reviews (2024) Vol. 37, Iss. 4
Closed Access | Times Cited: 2
Distinct Features of Vascular Diseases in COVID-19
Alexandr Ceasovschih, Victorița Șorodoc, Annabelle Shor, et al.
Journal of Inflammation Research (2023) Vol. Volume 16, pp. 2783-2800
Open Access | Times Cited: 6
SARS-CoV-2 nucleocapsid protein promotes TMAO-induced NLRP3 inflammasome activation by SCAP–SREBP signaling pathway
Mi‐Hua Liu, Xiaolong Lin, Le-Le Xiao
Tissue and Cell (2023) Vol. 86, pp. 102276-102276
Closed Access | Times Cited: 6
The possible role of nuclear factor erythroid‐2‐related factor 2 activators in the management of Covid‐19
Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, Omayma A. Eldahshan, et al.
Journal of Biochemical and Molecular Toxicology (2023) Vol. 38, Iss. 1
Closed Access | Times Cited: 6
Coronavirus Disease-2019 and Stroke: Pathophysiology and Management
Coulter Small, Yusuf Mehkri, E Panther, et al.
Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques (2022) Vol. 50, Iss. 4, pp. 495-502
Open Access | Times Cited: 11
Central Effects of Ivermectin in Alleviation of Covid-19-induced Dysauto-nomia
Αθανάσιος Αλεξίου, Gaber El‐Saber Batiha, Hayder M. Al‐kuraishy, et al.
Current Drug Targets (2022) Vol. 23, Iss. 13, pp. 1277-1287
Closed Access | Times Cited: 10
The possible role furin and furin inhibitors in endometrial adenocarcinoma: A narrative review
Hayder M. Al‐kuraishy, Thabat J. Al‐Maiahy, Ali I. Al‐Gareeb, et al.
Cancer Reports (2023) Vol. 7, Iss. 1
Open Access | Times Cited: 5
Page 1 - Next Page

Scroll to top